BMI-stratified analysis: medication-specific ocular protection patterns The BMI-stratified subgroup analysis revealed no statistically significant differences between Tirzepatide and Semaglutide across primary ocular outcomes (Supplementary Fig
Titration ran through 2.5, 5, 7.5, 10, 12.5, and 15 mg
People prescribed Mounjaro will be able to take it for as long as necessary, whereas Nice has imposed a two-year limit on the use of Wegovy
All of the disproportionality signals had early failure type characteristics, suggesting that the majority of patients developed gastrointestinal AEs within 1 week or 1 month of semaglutide treatment, and that the risk of gastrointestinal AEs occurrence gradually decreased over time
By targeting specific receptors in the brain, were able to help patients feel fuller for longer periods while simultaneously slowing gastric emptying